spacer
spacer

PDBsum entry 3uir

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
3uir
Contents
Protein chains
243 a.a.
56 a.a.
Ligands
SO4 ×2
Waters ×104

References listed in PDB file
Key reference
Title The structure of human microplasmin in complex with textilinin-1, An aprotinin-Like inhibitor from the australian brown snake.
Authors E.K.Millers, L.A.Johnson, G.W.Birrell, P.P.Masci, M.F.Lavin, J.De jersey, L.W.Guddat.
Ref. Plos One, 2013, 8, e54104.
PubMed id 23335990
Note In the PDB file this reference is annotated as "TO BE PUBLISHED". The citation details given above were identified by an automated search of PubMed on title and author names, giving a percentage match of 96%.
Abstract
Textilinin-1 is a Kunitz-type serine protease inhibitor from Australian brown snake venom. Its ability to potently and specifically inhibit human plasmin (K(i) = 0.44 nM) makes it a potential therapeutic drug as a systemic anti-bleeding agent. The crystal structures of the human microplasmin-textilinin-1 and the trypsin-textilinin-1 complexes have been determined to 2.78 Å and 1.64 Å resolution respectively, and show that textilinin-1 binds to trypsin in a canonical mode but to microplasmin in an atypical mode with the catalytic histidine of microplasmin rotated out of the active site. The space vacated by the histidine side-chain in this complex is partially occupied by a water molecule. In the structure of microplasminogen the χ(1) dihedral angle of the side-chain of the catalytic histidine is rotated by 67° from its "active" position in the catalytic triad, as exemplified by its location when microplasmin is bound to streptokinase. However, when textilinin-1 binds to microplasmin the χ(1) dihedral angle of this amino acid residue changes by -157° (i.e. in the opposite rotation direction compared to microplasminogen). The unusual mode of interaction between textilinin-1 and plasmin explains textilinin-1's selectivity for human plasmin over plasma kallikrein. This difference can be exploited in future drug design efforts.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer